Posted in | News | Nanoenergy | Nanobusiness

Cavitation Technologies Enters into Agreement to Evaluate Nano Cavitation Reactor Technology

Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT; Berlin: WTC) commented today that it has entered into an agreement with Desmet Ballestra Group to evaluate CTI's Nano Cavitation Reactor technology and its potential benefits to the vegetable oil industry.

Desmet Ballestra is known for their specialized expertise and are the market leaders in the field of the extraction and refining of oils and fats from oleaginous materials and the conversion of crude oils and fats into value-added products such as edible oil, shortening, biodiesel, detergents, surfactants and soap.

Speaking on behalf of Cavitation Technologies, Mr. Roman Gordon, CEO said: "We are very pleased to be working with the Desmet Ballestra Group and look forward to our cooperation in the vegetable oil industry. We expect their knowledge, experience, expertise and leadership will help us realize the full worldwide potential of our technology."

CTI's new GPD system is based on its patented flow-through Nano Cavitation Reactor technology that promotes the formation, growth, and implosive collapse of gas or vapor-filled bubbles in liquids. The process involves the mixing of crude vegetable oil and water and exposing them to high-pressure impulses and micro explosions at the molecular level causing the gums to become denser thus allowing efficient separation and higher oil yields.

This environmentally friendly technology represents a significant advancement over current 40-year-old process techniques.

Cavitation Technologies, Inc. (CTI); (OTC: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, chemical industries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.